The Safer Prescription of Opioids Tool USA Market feasibility study

更安全的阿片类药物处方工具美国市场可行性研究

• 批准号: 10018146
• 金额: $ 2.67万
• 依托单位: DOCTOR FLINT LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10018146
• 关键词: Safer; Prescription; Opioids; Tool; USA

SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has been included in the Scottish Government's Coronavirus 19 palliative care response toolkit.Following a recent IUK project, SPOT has partnered with a UK and European-based professional publishing distributor, Class Professional Publishing. As of April 2021, SPOT is now available Europe-wide on their Salesforce platform, complemented with first-line sales and technical support.Building on specific contacts engendered over the last two years, our progress in the UK and European markets, and an increase in momentum for digital health from the COVID-19 pandemic, we seek to carry out a feasibility study with potential commercial partners in the USA who have already expressed interest in SPOT.

Spot-阿片类药物工具的更安全处方是一个新颖的数字健康平台，以软件作为服务分发，事实证明，它可以显着提高阿片类药物处方和遵守最佳实践指南的信心。 BBC曾出现Spot，并且是SDI在2020年观看的前12名数字健康创新之一。 Spot已包含在苏格兰政府的冠状病毒19姑息治疗响应工具包中。遵循最新的IUK项目，Spot已与英国和欧洲和欧洲的专业出版商班级专业出版公司合作。截至2021年4月，现已在其Salesforce平台上范围内的欧洲范围内供应一线销售和技术支持。建立过去两年中的特定联系，我们在英国和欧洲市场的进步，以及在COVID-19 Pandemic的数字健康方面的增长，我们寻求与潜在的商业派对进行浮雕研究，他们已经表现出了在美国的现场研究。